Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1619, 2008-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Homoharringtonine + IFN- efficacious in chronic-phase CML
Inpharma, Vol. 1, Iss. 1339, 2002-01 ,pp. :
Access to resources
Recommend
Dasatinib off to a good start in imatinib-resistant CML
Inpharma, Vol. 1, Iss. 1523, 2006-01 ,pp. :
Dasatinib tops imatinib for CML on economic level
Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. :
Dasatinib tops imatinib for CML on economic level
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. :
Dasatinib: a once-daily option for imatinib-resistant CML
Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. :